Login Register Cart 0
Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Comparison of Liver Fibrosis and Function Indices with Extracellular Volume Using Dual-energy CT: A Retrospective Study

Author(s): Reiji Kokubo*, Kazuhiro Saito, Takafumi Yamada, Taro Tanaka, Yu Tajima and Kunihito Suzuki

Volume 18, Issue 11, 2022

Published on: 23 May, 2022

Article ID: e070422203236 Pages: 6

DOI: 10.2174/1573405618666220407100237

Price: $65

Abstract

Background: Dual-Energy Computed Tomography (DECT) enables the direct measurement of iodine accumulation in the extracellular space.

Objective: To compare measures of liver fibrosis and function with Extracellular Volume (ECV) from iodine/water images using DECT.

Methods: Data was obtained from 119 consecutive patients who underwent abdominal DECT. A region of interest was set in the right lobe of the liver, pancreas, spleen, and aorta on iodine density images. ECV was calculated using the following formula: ECV = (1 − hematocrit) × [iodine concentration in the liver (or pancreas, spleen) / iodine concentration in the aorta]. The severity of liver fibrosis was estimated using the aminotransferase/platelet ratio index (APRI) and the Fibrosis-4 (FIB-4) index. Liver function was assessed by the Child-Pugh classification and albumin-bilirubin (ALBI) grade. Data were analyzed by the Spearman rank correlation coefficient, one-way analysis of variance, and post hoc analysis.

Results: The correlation between ECV and fibrosis indices (APRI and FIB-4) was only significant, with a weak magnitude for liver ECV quantification at the equilibrium phase (r=0.25 and r=0.20, respectively). The correlations between liver function index and ECV quantification were more robust than with fibrosis index. The highest correlations (r=0.50) were found between ALBI grade and liver ECV at the equilibrium phase. Liver ECV values at the equilibrium phase had a significant difference between ALBI grade 1 vs. 2 and grade 1 vs. 3.

Conclusion: Liver ECV quantification by DECT is more suitable for evaluating liver function than liver fibrosis severity.

Keywords: Dual-energy CT, extracellular volume fraction, liver fibrosis, liver functional reserve, aminotransferase/platelet ratio index (APRI), Fibrosis-4 (FIB-4) index, Child-Pugh classification, albumin bilirubin (ALBI) grade.

Graphical Abstract

[1]
Nanashima A, Abo T, Arai J, Matsumoto H, Kudo T, Nagayasu T. Functional liver reserve parameters predictive for posthepatectomy com-plications. J Surg Res 2013; 185(1): 127-35.
[http://dx.doi.org/10.1016/j.jss.2013.05.021] [PMID: 23746962]
[2]
Shinkawa H, Takemura S, Tanaka S, Kubo S. Portal vein embolization: History and current indications. Visc Med 2017; 33(6): 414-7.
[http://dx.doi.org/10.1159/000479474] [PMID: 29344514]
[3]
Toosi AE. Liver fibrosis: Causes and methods of assessment, a review. Rom J Intern Med 2015; 53(4): 304-14.
[http://dx.doi.org/10.1515/rjim-2015-0039] [PMID: 26939206]
[4]
Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: A systematic review. Ann Intern Med 2013; 158(11): 807-20.
[http://dx.doi.org/10.7326/0003-4819-158-11-201306040-00005] [PMID: 23732714]
[5]
Hiraoka A, Kumada T, Kudo M, et al. Albumin-Bilirubin (ALBI) grade as part of the evidence-based clinical practice guideline for hcc of the japan society of hepatology: A comparison with the liver damage and child-pugh classifications. Liver Cancer 2017; 6(3): 204-15.
[http://dx.doi.org/10.1159/000452846] [PMID: 28626732]
[6]
Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade. J Clin Oncol 2015; 33(6): 550-8.
[http://dx.doi.org/10.1200/JCO.2014.57.9151] [PMID: 25512453]
[7]
Bottari A, Silipigni S, Carerj ML, et al. Dual-source dual-energy CT in the evaluation of hepatic fractional extracellular space in cirrhosis. Radiol Med (Torino) 2020; 125(1): 7-14.
[http://dx.doi.org/10.1007/s11547-019-01089-7] [PMID: 31587181]
[8]
Dong J, He F, Wang L, et al. Iodine density changes in hepatic and splenic parenchyma in liver cirrhosis with dual energy CT (DECT): A preliminary study. Acad Radiol 2019; 26(7): 872-7.
[http://dx.doi.org/10.1016/j.acra.2018.08.018] [PMID: 30262328]
[9]
Guo SL, Su LN, Zhai YN, et al. The clinical value of hepatic extracellular volume fraction using routine multiphasic contrast-enhanced liver CT for staging liver fibrosis. Clin Radiol 2017; 72(3): 242-6.
[http://dx.doi.org/10.1016/j.crad.2016.10.003] [PMID: 28341030]
[10]
Lamb P, Sahani DV, Fuentes-Orrego JM, Patino M, Ghosh A, Mendonça PR. Stratification of patients with liver fibrosis using dual-energy CT. IEEE Trans Med Imaging 2015; 34(3): 807-15.
[http://dx.doi.org/10.1109/TMI.2014.2353044] [PMID: 25181365]
[11]
Lv P, Lin X, Gao J, Chen K, Spectral CT. Preliminary studies in the liver cirrhosis. Korean J Radiol 2012; 13(4): 434-42.
[http://dx.doi.org/10.3348/kjr.2012.13.4.434] [PMID: 22778565]
[12]
Sofue K, Tsurusaki M, Mileto A, et al. Dual-energy computed tomography for non-invasive staging of liver fibrosis: Accuracy of iodine density measurements from contrast-enhanced data. Hepatol Res 2018; 48(12): 1008-19.
[http://dx.doi.org/10.1111/hepr.13205] [PMID: 29908040]
[13]
Zissen MH, Wang ZJ, Yee J, Aslam R, Monto A, Yeh BM. Contrast-enhanced CT quantification of the hepatic fractional extracellular space: Correlation with diffuse liver disease severity. AJR Am J Roentgenol 2013; 201(6): 1204-10.
[http://dx.doi.org/10.2214/AJR.12.10039] [PMID: 24261358]
[14]
Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60(8): 646-9.
[http://dx.doi.org/10.1002/bjs.1800600817] [PMID: 4541913]
[15]
Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38(2): 518-26.
[http://dx.doi.org/10.1053/jhep.2003.50346] [PMID: 12883497]
[16]
Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006; 43(6): 1317-25.
[http://dx.doi.org/10.1002/hep.21178] [PMID: 16729309]
[17]
Patino M, Prochowski A, Agrawal MD, et al. Material Separation Using Dual-Energy CT: Current and emerging applications. Radiographics 2016; 36(4): 1087-105.
[http://dx.doi.org/10.1148/rg.2016150220] [PMID: 27399237]
[18]
Yoon JH, Lee JM, Klotz E, et al. Estimation of hepatic extracellular volume fraction using multiphasic liver computed tomography for he-patic fibrosis grading. Invest Radiol 2015; 50(4): 290-6.
[http://dx.doi.org/10.1097/RLI.0000000000000123] [PMID: 25493416]
[19]
Bihari C, Rastogi A, Sen B, Bhadoria AS, Maiwall R, Sarin SK. Quantitative fibrosis estimation by image analysis predicts development of decompensation, composite events and defines event-free survival in chronic hepatitis B patients. Hum Pathol 2016; 55: 63-71.
[http://dx.doi.org/10.1016/j.humpath.2016.04.012]
[20]
Lautt WW, Greenway CV. Conceptual review of the hepatic vascular bed. Hepatology 1987; 7(5): 952-63.
[http://dx.doi.org/10.1002/hep.1840070527] [PMID: 3308669]
[21]
Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec’s cirrhosis. J Clin Invest 1953; 32(10): 1025-33.
[http://dx.doi.org/10.1172/JCI102813] [PMID: 13096569]
[22]
Henriksen JH, Møller S. Cardiac and systemic haemodynamic complications of liver cirrhosis. Scand Cardiovasc J 2009; 43(4): 218-25.
[http://dx.doi.org/10.1080/14017430802691528] [PMID: 19145534]
[23]
Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilation hypothesis: A proposal for the initia-tion of renal sodium and water retention in cirrhosis. Hepatology 1988; 8(5): 1151-7.
[http://dx.doi.org/10.1002/hep.1840080532] [PMID: 2971015]
[24]
Sumida Y, Yoneda M, Hyogo H, et al. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterol 2012; 12: 2.
[http://dx.doi.org/10.1186/1471-230X-12-2]

Rights & Permissions Print Cite
Article Metrics
42
1
© 2024 Bentham Science Publishers | Privacy Policy